James Hammond
Pharmacology
University of Alberta
Canada
Biography
James Hammond is a professor belongs to the Department of pharmacology from the university of Alberta.
Research Interest
The research focus of the Hammond laboratory is on the pharmacological, functional and molecular characterization of the membrane transport systems responsible for the uptake and release of endogenous nucleosides and anticancer/antiviral nucleoside analogues by mammalian cells. Adenosine, the primary physiological substrate for these transporters, is an endogenous bioactive agent with neuromodulator, cardioprotective and vasodilator activities. These actions of adenosine are mediated through extracellular membrane-located adenosine receptors. Uptake into cells via nucleoside transporters is the first step in the metabolism and inactivation of extracellular nucleosides and these transport systems thereby play a significant role in controlling the bioactivity of adenosine.
Publications
-
Hughes SJ, Cravetchi X, Vilas G and Hammond JR. (2015) Adenosine A1 receptor activation modulates human equilibrative nucleoside transporter 1 (hENT1) activity via PKC-mediated phosphorylation of serine-281. Cell Signal 27(5):1008-18. PMID: 25725289.
-
Ii H, Warraich S, Tenn N, Quinonez D, Holdsworth DW, Hammond JR, Dixon SJ and Séguin CA. (2016) Disruption of biomineralization pathways in spinal tissues of a mouse model of diffuse idiopathic skeletal hyperostosis. Bone 90:37-49. PMID: 27237608